CUPR Market Analysis
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-0.790.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$4.3MMicro cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 1.97
- P/S (TTM)
- 85.98
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -1569.0%
- Operating margin
- -10568.0%
- Revenue growth YoY
- 267.4%
- Dividend yield
- —
- Beta
- —
Last earnings
Dec 9, 2025 · Estimate $0.00 · Reported $-0.10
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Company profileCuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- BLK 1090, SINGAPORE, SINGAPORE
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$4.3M
Shares outstanding$920640
52W high$11.68
52W low$1.45
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent